Publications by authors named "Amaia Camara-Otegui"
Article Synopsis
- - Spain introduced universal RSV prophylaxis in the 2023-2024 season, allowing all newborns to receive nirsevimab, particularly benefiting infants under 6 months through extended immunization efforts.
- - A study in 15 pediatric emergency departments showed significant decreases in respiratory infections: a 57.7% drop in lower respiratory tract infections and a 63.1% reduction in hospital and PICU admissions related to acute bronchiolitis.
- - The findings indicate that nirsevimab is highly effective in protecting infants from RSV, with extended catch-up immunization yielding the best results, although cost-effectiveness remains a consideration.
Importance: Ileocolic intussusception is an important cause of intestinal obstruction in children. Reduction of ileocolic intussusception using air or fluid enema is the standard of care. This likely distressing procedure is usually performed without sedation or analgesia, but practice variation exists.
View Article and Find Full Text PDF